GreenMark Biomedical Inc. announced that the company raised $830,000 in equity financing in the form of convertible notes in anticipation of a Series A financing in 2022.
Continue Reading >GreenMark Biomedical Inc. announced that the company raised $830,000 in equity financing in the form of convertible notes in anticipation of a Series A financing in 2022.
Read MoreSeptember 8, 2021 – GreenMark Biomedical Inc. announced the company has been selected as a 2021 Cellerant Best of Class Technology Award recipient. “During what is once again proving to be a very challenging year for the dental industry, each of these extraordinary companies and their award winning technologies have earned the right to celebrate. I […]
Read MoreAugust 24, 2020 – GreenMark Biomedical Inc. announced that the company raised $1.74M in equity financing in the form of convertible notes in anticipation of a Series A financing in 2021
Read MoreMay 20, 2020 – GreenMark Biomedical Inc. along with its collaborators at the University of Michigan (U-M) today announced that its technology on regenerative treatment of tooth enamel has received support at up to $913,000 from the Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center (NIH grant number: U24-DE029462).
Read MoreApril 8, 2021 – GreenMark Biomedical Inc. announced that the company has secured regulatory clearance from the U.S. Food and Drug Administration (FDA) to market its LumiCare™ Caries Detection Rinse as a 510(k) Class II Medical Device. “Gaining FDA clearance for our LumiCare™ device at this particular time is especially gratifying given the significant pandemic challenges […]
Read More
March 8, 2021 – Thank you for visiting us at our booth at the virtual Midwinter Meeting! We cherish the opportunity to connect with all of you. This past year has been challenging for most of us. We appreciate that you used your time to come learn about GreenMark and LumiCare™ Caries Detection Rinse.
Read More
Technological innovations and increased knowledge of the oral microbiome can help our patients maintain oral health and improve oral health outcomes. March 2021 – Advances in technology and the availability of chairside testing have enabled us to better prevent, diagnose, and treat oral disease. Read the article at Dental Products Report
Read More
October 21, 2020 – GreenMark Biomedical founder and CEO Steven Bloembergen, Ph.D. explains the new LumiCare™ Caries Detection Rinse which was named a 2020 Cellerant Best of Class Technology award winner.
Read More